FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225550829> ?p ?o ?g. }

• W4225550829 endingPage "92" @default.
• W4225550829 startingPage "88" @default.
• W4225550829 abstract "Granulomatosis with polyangiitis (GPA), formerly known as Wegner's granulomatosis, is a rare vasculitic syndrome classified under Anti-Neutrophilic Cytoplasmic Autoantibody (ANCA)-associ- ated vasculitides, which is fatal if untreated. The mainstay of treatment consists of immunosuppression using a combination of corticosteroids with either rituximab (RTX) or cyclophosphamide (CYC). We aimed to compare the 4-year clinical outcomes between patients with GPA receiving CYC and RTX as remission induction.In this retrospective cohort, we used patient data from 92 patients with GPA at two large teaching hospitals and a private clinic in Isfahan, Iran. The patients were classified based on the medi- cation they received for remission induction into RTX and CYC groups. The main outcomes were rate of death and relapse, disease activity assessed based on the Birmingham Vasculitis Activity Score (BVAS), disease-related complications, laboratory markers, and adverse-drug-reactions.Fifty-three (57.6%) patients received CYC, whereas 39 (42.4%) received RTX. The mean duration of follow-up was 3.6 (62) years. Most of patients (70%) had a successful remission, while 20.7% experi- enced a relapse and 8.7% of patients died. The rate of death and relapse did not differ between the RTX and CYC groups. Disease-related complications involved an insignificantly higher proportion of patients in the CYC (12/53) group than the RTX (4/39) group. Patients in both groups showed a signifi- cant decrease in BVAS during follow-ups irrespective of the medication exposure. The rate of adverse events was similarly low (n 1⁄4 1) in both groups.RTX and CYC were similar in inducing remission and reducing adverse clinical outcomes among patients with GPA with acceptable side effect profiles." @default.
• W4225550829 created "2022-05-05" @default.
• W4225550829 creator A5011973823 @default.
• W4225550829 creator A5032646203 @default.
• W4225550829 creator A5036185270 @default.
• W4225550829 date "2022-04-29" @default.
• W4225550829 modified "2023-10-14" @default.
• W4225550829 title "A comparison of rituximab with cyclophosphamide in terms of efficacy and complications as induction therapy for treating granulomatosis with polyangiitis: A three-center study" @default.
• W4225550829 cites W1914343637 @default.
• W4225550829 cites W1964913193 @default.
• W4225550829 cites W1967599448 @default.
• W4225550829 cites W2010862163 @default.
• W4225550829 cites W2011309580 @default.
• W4225550829 cites W2031517139 @default.
• W4225550829 cites W2046059252 @default.
• W4225550829 cites W2063340779 @default.
• W4225550829 cites W2069023541 @default.
• W4225550829 cites W2084056567 @default.
• W4225550829 cites W2090669047 @default.
• W4225550829 cites W2101093436 @default.
• W4225550829 cites W2140722155 @default.
• W4225550829 cites W2163003110 @default.
• W4225550829 cites W2266467924 @default.
• W4225550829 cites W2322363031 @default.
• W4225550829 cites W2474029657 @default.
• W4225550829 cites W249810009 @default.
• W4225550829 cites W2584442866 @default.
• W4225550829 cites W2647919720 @default.
• W4225550829 cites W3081393921 @default.
• W4225550829 doi "https://doi.org/10.5152/eurjrheum.2022.21063" @default.
• W4225550829 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35546333" @default.
• W4225550829 hasPublicationYear "2022" @default.
• W4225550829 type Work @default.
• W4225550829 citedByCount "1" @default.
• W4225550829 countsByYear W42255508292022 @default.
• W4225550829 crossrefType "journal-article" @default.
• W4225550829 hasAuthorship W4225550829A5011973823 @default.
• W4225550829 hasAuthorship W4225550829A5032646203 @default.
• W4225550829 hasAuthorship W4225550829A5036185270 @default.
• W4225550829 hasBestOaLocation W42255508291 @default.
• W4225550829 hasConcept C126322002 @default.
• W4225550829 hasConcept C141071460 @default.
• W4225550829 hasConcept C159654299 @default.
• W4225550829 hasConcept C163764329 @default.
• W4225550829 hasConcept C167135981 @default.
• W4225550829 hasConcept C179755657 @default.
• W4225550829 hasConcept C197934379 @default.
• W4225550829 hasConcept C203014093 @default.
• W4225550829 hasConcept C2776015282 @default.
• W4225550829 hasConcept C2776694085 @default.
• W4225550829 hasConcept C2776755627 @default.
• W4225550829 hasConcept C2778910314 @default.
• W4225550829 hasConcept C2779134260 @default.
• W4225550829 hasConcept C2779338263 @default.
• W4225550829 hasConcept C2780252810 @default.
• W4225550829 hasConcept C2780653079 @default.
• W4225550829 hasConcept C2781229154 @default.
• W4225550829 hasConcept C71924100 @default.
• W4225550829 hasConcept C90924648 @default.
• W4225550829 hasConceptScore W4225550829C126322002 @default.
• W4225550829 hasConceptScore W4225550829C141071460 @default.
• W4225550829 hasConceptScore W4225550829C159654299 @default.
• W4225550829 hasConceptScore W4225550829C163764329 @default.
• W4225550829 hasConceptScore W4225550829C167135981 @default.
• W4225550829 hasConceptScore W4225550829C179755657 @default.
• W4225550829 hasConceptScore W4225550829C197934379 @default.
• W4225550829 hasConceptScore W4225550829C203014093 @default.
• W4225550829 hasConceptScore W4225550829C2776015282 @default.
• W4225550829 hasConceptScore W4225550829C2776694085 @default.
• W4225550829 hasConceptScore W4225550829C2776755627 @default.
• W4225550829 hasConceptScore W4225550829C2778910314 @default.
• W4225550829 hasConceptScore W4225550829C2779134260 @default.
• W4225550829 hasConceptScore W4225550829C2779338263 @default.
• W4225550829 hasConceptScore W4225550829C2780252810 @default.
• W4225550829 hasConceptScore W4225550829C2780653079 @default.
• W4225550829 hasConceptScore W4225550829C2781229154 @default.
• W4225550829 hasConceptScore W4225550829C71924100 @default.
• W4225550829 hasConceptScore W4225550829C90924648 @default.
• W4225550829 hasIssue "2" @default.
• W4225550829 hasLocation W42255508291 @default.
• W4225550829 hasLocation W42255508292 @default.
• W4225550829 hasLocation W42255508293 @default.
• W4225550829 hasOpenAccess W4225550829 @default.
• W4225550829 hasPrimaryLocation W42255508291 @default.
• W4225550829 hasRelatedWork W2005449894 @default.
• W4225550829 hasRelatedWork W2077982979 @default.
• W4225550829 hasRelatedWork W2133531497 @default.
• W4225550829 hasRelatedWork W2183655738 @default.
• W4225550829 hasRelatedWork W2331407017 @default.
• W4225550829 hasRelatedWork W2760216409 @default.
• W4225550829 hasRelatedWork W3035913527 @default.
• W4225550829 hasRelatedWork W3197765824 @default.
• W4225550829 hasRelatedWork W4225550829 @default.
• W4225550829 hasRelatedWork W4367369413 @default.
• W4225550829 hasVolume "9" @default.
• W4225550829 isParatext "false" @default.
• W4225550829 isRetracted "false" @default.
• W4225550829 workType "article" @default.